Pugliese Nicola, Ponziani Francesca Romana, Cerini Federica, di Tommaso Luca, Turati Federica, Maggioni Marco, Manini Matteo Angelo, Santopaolo Francesco, Bianco Cristiana, Masetti Chiara, Giustiniani Maria Cristina, La Vecchia Carlo, Valenti Luca, Terracciano Luigi, Viganò Mauro, Aghemo Alessio
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (MI), Italy.
Division of Internal Medicine and Hepatology, Department of Gastroenterology, IRCCS Humanitas Research Hospital, Rozzano, MI, Italy.
JHEP Rep. 2024 Jun 23;6(9):101150. doi: 10.1016/j.jhepr.2024.101150. eCollection 2024 Sep.
BACKGROUND & AIMS: Porto-sinusoidal vascular disorder (PSVD) is a group of vascular disorders characterized by lesions involving portal venules and sinusoids, irrespective of the presence of portal hypertension. Liver biopsy is essential for diagnosis. In a single-center study, we demonstrated high rates of PSVD in patients with persistently elevated gamma-glutamyltransferase (GGT). This multicenter study aims to establish PSVD prevalence in a larger dataset of individuals with persistent and unexplained GGT elevation, and to identify associated risk factors.
The study included all patients who underwent liver biopsy for persistent and unexplained GGT elevation in five Italian hepatology units between March 2015 and December 2021.
A total of 144 patients met the inclusion criteria. The majority were males (76/144, 52.8%) and mean age was 51.9 years (range 19-74). Only 12 (8.3%) had liver stiffness measurements (LSM) >10 kPa, while 7 (4.8%) had ultrasound evidence of portal hypertension. Histological findings were consistent with PSVD in 96 patients (67%). Alternative diagnoses were steatohepatitis in 13 (9%), sarcoidosis in 3 (2%) and congenital hepatic fibrosis in 3 (2%) patients. Histological findings were non-specific in 29 (20%) patients. PSVD was associated with male sex (odds ratio [OR] 2.60, 95% CI 1.13-5.99), LSM <10 kPa (OR 11.05, 95% CI 2.16-56.66) and GGT <200 U/L (OR 2.69, 95% CI 1.22-5.98).
PSVD was the main cause of persistent and unexplained elevation of GGT3. Male sex, LSM <10 kPa and GGT <200 U/L were associated with PSVD. These findings highlight the role of liver biopsy in elucidating the underlying pathology and aiding in the diagnosis of patients with persistent and unexplained GGT elevation.
In outpatient settings, it is common to encounter individuals with persistent and unexplained gamma-glutamyltransferase elevations. This study reveals, for the first time, a non-negligible prevalence of porto-sinusoidal vascular disorder among these individuals when they undergo liver biopsy. Male sex, liver stiffness measurement <10 kPa, and gamma-glutamyltransferase <200 IU/L predict this histological finding. These results may raise awareness of clinically relevant conditions that may be present in patients with persistent liver enzyme changes, even in the absence of signs of advanced chronic liver disease or portal hypertension. Additionally, the data may encourage further studies in the field of porto-sinusoidal vascular disorder, particularly to define its clinical evolution in patients without signs of portal hypertension at diagnosis.
门静脉窦状隙血管疾病(PSVD)是一组血管疾病,其特征为累及门静脉小分支和肝血窦的病变,无论是否存在门静脉高压。肝活检对诊断至关重要。在一项单中心研究中,我们发现γ-谷氨酰转移酶(GGT)持续升高的患者中PSVD发生率很高。这项多中心研究旨在确定在更大的持续性不明原因GGT升高个体数据集中PSVD的患病率,并识别相关危险因素。
该研究纳入了2015年3月至2021年12月期间在意大利五个肝病科因持续性不明原因GGT升高接受肝活检的所有患者。
共有144例患者符合纳入标准。大多数为男性(76/144,52.8%),平均年龄为51.9岁(范围19 - 74岁)。只有12例(8.3%)肝脏硬度测量值(LSM)>10 kPa,而7例(4.8%)有门静脉高压的超声证据。96例患者(67%)的组织学检查结果符合PSVD。其他诊断包括13例(9%)脂肪性肝炎、3例(2%)结节病和3例(2%)先天性肝纤维化。29例(20%)患者的组织学检查结果无特异性。PSVD与男性性别(比值比[OR] 2.60,95%置信区间1.13 - 5.99)、LSM <10 kPa(OR 11.05,95%置信区间2.16 - 56.66)和GGT <200 U/L(OR 2.69,95%置信区间1.22 - 5.98)相关。
PSVD是GGT持续不明原因升高的主要原因。男性性别、LSM <10 kPa和GGT <200 U/L与PSVD相关。这些发现突出了肝活检在阐明潜在病理及辅助诊断持续性不明原因GGT升高患者中的作用。
在门诊环境中,经常会遇到GGT持续不明原因升高的个体。本研究首次揭示,在这些个体接受肝活检时,门静脉窦状隙血管疾病的患病率不可忽视。男性性别、肝脏硬度测量值<10 kPa和γ-谷氨酰转移酶<200 IU/L可预测这一组织学发现。这些结果可能会提高对持续性肝酶变化患者中可能存在的临床相关情况(即使在无晚期慢性肝病或门静脉高压迹象时)的认识。此外,这些数据可能会鼓励在门静脉窦状隙血管疾病领域进行进一步研究,特别是确定其在诊断时无门静脉高压迹象患者中的临床演变。